<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000533413"><TermName>ABT-263</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of lymphomas and other types of cancer. It blocks some of the enzymes that keep cancer cells from dying. It is a type of Bcl-2 family inhibitor. Also called navitoclax.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>ABT-263</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de los linfomas y otros tipos de cáncer. Bloquea algunas de las enzimas que impiden que las células cancerosas mueran. Es un tipo de inhibidor de la familia Bcl-2. También se llama navitoclax.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-06-21</DateFirstPublished></GlossaryTerm>
